ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 27 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $956,000 | -40.7% | 248,992 | -38.8% | 0.03% | -53.0% |
| Q3 2019 | $1,611,000 | -8.0% | 406,926 | -2.2% | 0.07% | +4.8% |
| Q2 2019 | $1,751,000 | -46.3% | 415,908 | -12.5% | 0.06% | -49.6% |
| Q1 2019 | $3,262,000 | +86.4% | 475,450 | 0.0% | 0.12% | +78.6% |
| Q4 2018 | $1,750,000 | -54.9% | 475,450 | -22.4% | 0.07% | -49.6% |
| Q3 2018 | $3,879,000 | -43.9% | 612,867 | -32.9% | 0.14% | -42.8% |
| Q2 2018 | $6,912,000 | -5.4% | 913,100 | 0.0% | 0.24% | -4.0% |
| Q1 2018 | $7,305,000 | -28.6% | 913,100 | 0.0% | 0.25% | -37.1% |
| Q4 2017 | $10,227,000 | -5.5% | 913,100 | -2.1% | 0.40% | -17.6% |
| Q3 2017 | $10,824,000 | – | 933,100 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |